Cannabis Stocks to Watch: Tilray, Canopy Growth, and Greenlane Gain Momentum


Green stock chart with cannabis leaf icon and upward arrows, symbolizing growth and rising investor confidence in cannabis companies like Tilray, Canopy Growth, and Greenlane.


Investor attention is turning back toward cannabis. Publicly traded companies like Tilray Brands, Canopy Growth Corporation, and Greenlane Holdings have seen a surge in trading activity, driven by renewed optimism around potential federal cannabis reform and international market expansion.

After several years of volatility, the cannabis sector is showing fresh signs of life. The uptick in volume and sentiment suggests investors are positioning themselves ahead of possible regulatory shifts — particularly the ongoing discussion around federal rescheduling and broader access to banking and investment opportunities.

If your business operates in or around the cannabis space, now’s the time to strengthen your foundation. Start with our quick Cannashield intake form to protect your operation and prepare for industry growth.


Renewed Investor Confidence in Cannabis Markets

The cannabis industry has spent the past few years navigating headwinds — from price compression and high taxes to regulatory delays and limited banking access. But the tide is turning. Recent policy conversations, coupled with progress at the state level and growing global demand, have brought cannabis back to investors’ radar.

Tilray Brands: Expanding Beyond North America

Tilray Brands (NASDAQ: TLRY) continues to be a major player in international cannabis. With active operations across Canada, the U.S., and Europe, Tilray has been strategically diversifying into beverages, wellness products, and hemp-based goods. Its ability to pivot toward consumer-packaged goods has helped offset market challenges in Canada while positioning it for growth once U.S. reform accelerates.
Tilray’s stock has seen increased momentum as investors respond to both diversification efforts and broader optimism around potential rescheduling. The company’s strong brand portfolio — combined with its ongoing acquisition strategy — makes it a key stock to watch for long-term cannabis exposure.

Canopy Growth Corporation: Restructuring Toward Profitability

Canopy Growth (NASDAQ: CGC) has been a bellwether for cannabis since the early days of legalization. After years of restructuring and strategic downsizing, the company is now focused on stabilizing operations and regaining profitability.
What’s drawing investor attention now is Canopy’s move to consolidate its U.S. operations under Canopy USA, which gives it access to American assets including Acreage Holdings and Jetty Extracts. If federal rescheduling or the SAFER Banking Act passes, Canopy’s presence in the U.S. could give it a first-mover advantage.

Greenlane Holdings: Leaner and More Focused

Greenlane Holdings (NASDAQ: GNLN), once primarily a distributor of accessories and hardware, has been streamlining its operations to focus on profitability and product innovation. The company’s focus on cost-cutting and strategic partnerships has helped it weather market volatility.
With consumer trends shifting toward value-based cannabis retail and efficient supply chain models, Greenlane’s emphasis on adaptability is resonating with investors looking for companies that can survive — and grow — in a consolidating market.

If your company is preparing for growth or investment in a rapidly evolving industry, Complete our Cannashield questionnaire to ensure your compliance, coverage, and strategy are aligned with market realities.


Why Regulatory Developments Matter More Than Ever

Cannabis stocks are highly sensitive to federal and international policy changes. The U.S. Department of Health and Human Services’ recommendation to reschedule cannabis from Schedule I to Schedule III has renewed optimism across the market. While the final outcome remains uncertain, the conversation alone has triggered speculative buying and greater trading volume across major cannabis equities.

Beyond the U.S., international markets are also expanding. Germany’s move toward adult-use cannabis, coupled with ongoing reform discussions in the U.K. and Latin America, is creating long-term growth opportunities for companies with global reach.

However, investors and operators alike should remain cautious. While policy momentum is accelerating, timelines for implementation remain unpredictable — and volatility remains a hallmark of cannabis markets.

What This Means for the Industry

The renewed investor attention in cannabis stocks highlights a simple truth: the industry is entering its next phase of maturity. As operators focus on efficiency, quality, and compliance, institutional investors are beginning to revisit the space with a more strategic mindset.

For businesses within the cannabis supply chain — from cultivators and processors to technology providers and insurers — this resurgence underscores the importance of operational discipline. When capital flows back into the market, the best-prepared companies will be the ones to benefit.

This includes having strong insurance protection, compliance infrastructure, and risk management frameworks in place. Cannabis companies that demonstrate reliability and regulatory transparency will attract both consumers and investors — while minimizing exposure to the unpredictable nature of emerging markets.

Don’t wait for market conditions to shift before protecting your business. Fill out our Cannashield intake form to build a proactive compliance and insurance strategy that supports long-term growth.


Conclusion

The latest trading momentum around Tilray, Canopy Growth, and Greenlane shows that investor optimism in cannabis is returning. With policy reform gaining traction and companies evolving toward profitability and global reach, the industry’s next chapter is beginning to unfold.

Still, success in cannabis isn’t just about timing the market — it’s about preparation, compliance, and resilience. For business owners and investors alike, the companies that will thrive in this next phase are those that treat risk management as strategy, not an afterthought.

At Cannashield, we help operators and entrepreneurs prepare for the inevitable growth cycles that define the cannabis industry — ensuring they’re protected when opportunity arrives.

Complete our full intake form here to secure your business, strengthen your compliance framework, and stay ready for the next wave of industry expansion.

Read the full article here →
Previous
Previous

Pennsylvania Moves Toward a Cannabis Control Board

Next
Next

MariMed Expands Into New York’s $6 Billion Cannabis Market